clopidogrel
Ligand Summary
A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.
UNII: A74586SNO7
PubChem: 60606
ChEMBL: CHEMBL1771
DrugCentral: 708
LyCHI: A2KHQ3U645YJ
Target Activities
SLC6A4
Sodium-dependent serotonin transporter
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 6.52 | None, None:None:None | ||||
IC50 | 6.25 | None, None:None:None | ||||
CYP2B6
Cytochrome P450 2B6
2 Activities
P2RY12
P2Y purinoceptor 12
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 6.9 | ANTAGONIST | ||||